吸入麻醉市场规模、份额和成长分析（按药物、最终用户和地区）：产业预测（2024-2031）

2022年全球吸入麻醉市场规模约14.6亿美元，高于2023年的16亿美元，在预测期内（2024-2031年）复合年增长率为9.4%，预计将在2022年达到32.8亿美元。 2031.

由于几个重要因素，吸入麻醉市场预计在未来几年将显着成长。慢性病盛行率的上升和医疗机构对麻醉的需求不断增加预计将显着促进吸入麻醉产品的销售。此外，全球外科手术的增加在分析期间及之后对吸入麻醉的需求增加起着关键作用。麻醉技术的创新和对先进麻醉技术开发的增加投资正在为市场扩张开闢新的途径。此外，老年人口的增加以及对专门儿科麻醉的需求不断增加将进一步促进吸入麻醉市场的长期成长。然而，从长远来看，与麻醉相关的潜在健康併发症、熟练麻醉师的短缺以及与先进麻醉输送系统相关的高成本等挑战可能会阻碍吸入麻醉市场的需求。总体而言，儘管存在需要克服的障碍，但吸入麻醉的整体前景仍然乐观，医疗领域存在许多成长和创新的机会。

目录

介绍

• 分析目的
• 定义
• 市场范围

分析方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 价值链分析
• 案例研究分析
• 监管环境
• 技术分析

吸入麻醉市场：依药物划分

• 市场概况
• SEVOFLURANE
• DESFLURANE
• Isoflurane
• 其他的

吸入麻醉市场：依应用分类

• 市场概况
• 就职
• 维持

吸入麻醉市场：依最终用途分类

• 市场概况
• 医院
• 门诊手术中心
• 其他的

吸入麻醉市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲 (MEA)
  • 波湾合作理事会(GCC) 国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• 百特国际公司（美国）
• Halocarbon 产品公司（美国）
• 皮拉马尔重症监护（印度）
• 艾伯维公司（美国）
• 费森尤斯卡比股份公司（德国）
• GE医疗集团（美国）
• Hikma Pharmaceuticals PLC（英国）
• 林德公司（爱尔兰）
• Dragerwerk AG & Co. KGaA（德国）
• 迈瑞医疗国际有限公司 (中国)
• 深圳市陆风实业有限公司 (中国)
• 美敦力公司（爱尔兰）
• 美敦力公司（爱尔兰）
• 史密斯集团有限公司（英国）
• 泰利福公司（美国）
• Masimo 公司（美国）
• 潘隆有限公司（英国）
• Dameca A/S（丹麦）
• 索玛科技有限公司（美国）
• 纳朗医疗有限公司（印度）

Global Inhalation Anesthesia Market size was valued at around USD 1.46 billion in 2022 and is expected to rise from USD 1.60 billion in 2023 to reach a value of USD 3.28 billion by 2031, at a CAGR of 9.4% over the forecast period (2024-2031).

The inhalation anesthesia market is poised for substantial growth in the coming years, driven by several key factors. The rising prevalence of chronic diseases and an increasing demand for anesthesia in healthcare facilities are expected to significantly boost sales of inhalation anesthesia products. Additionally, the global uptick in surgical procedures plays a pivotal role in elevating the demand for inhalation anesthesia throughout the study period and beyond. Innovations in anesthetic technologies and heightened investments in developing advanced anesthetic techniques are opening new avenues for market expansion. Furthermore, the growing geriatric population, alongside the rising need for specialized pediatric anesthesia, will further contribute to the long-term growth of the inhalation anesthesia market. However, challenges such as potential health complications associated with anesthesia, a shortage of skilled anesthesiologists, and the high costs associated with advanced anesthesia delivery systems may hinder market demand in the long run. Overall, while there are obstacles to navigate, the overall outlook for inhalation anesthesia remains positive, with numerous opportunities for growth and innovation in the healthcare sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Inhalation Anesthesia market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Inhalation Anesthesia Market Segmental Analysis

Global Inhalation Anesthesia Market is segmented by Drug, Application End Use and region. Based on Drug, the market is segmented into Sevoflurane, Desflurane, Isoflurane, and Others. Based on Application, the market is segmented into Induction, and Maintenance. Based on End-Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Inhalation Anesthesia Market

The escalating prevalence of chronic diseases worldwide is driving a rising number of surgical procedures, significantly influencing the Global Inhalation Anesthesia market. As surgical interventions become increasingly common, the demand for effective and safe anesthesia options-such as inhalation agents-grows correspondingly. This trend highlights the essential role of anesthesia in facilitating complex surgeries and improving patient outcomes. Furthermore, advancements in inhalation anesthesia technologies and increasing awareness of their benefits enhance their adoption across healthcare settings. As healthcare systems adapt to address the surge in surgical needs, the inhalation anesthesia market is poised for substantial growth, creating lucrative opportunities for stakeholders.

Restraints in the Global Inhalation Anesthesia Market

One of the significant market restraints for the Global Inhalation Anesthesia market is the declining number of skilled anesthesiologists proficient in administering inhalation anesthesia. As the demand for surgical procedures rises globally, the shortage of qualified professionals willing and able to operate advanced anesthesia systems may hinder the effective implementation of inhalation anesthesia techniques. This scarcity is especially pronounced in underdeveloped and developing regions, where healthcare infrastructure may be lacking. Consequently, the insufficient pool of skilled anesthesiologists poses a barrier to market growth by limiting the accessibility and utilization of inhalation anesthesia, thereby potentially impacting patient outcomes and overall market expansion.

Market Trends of the Global Inhalation Anesthesia Market

The Global Inhalation Anesthesia market is witnessing a significant trend towards sustainable anesthetic agents, driven by increasing environmental awareness and stringent regulatory mandates. Manufacturers are prioritizing the development of inhalation anesthetics that minimize ecological impact, aligning with global sustainability goals. This shift not only addresses growing concerns about greenhouse gas emissions associated with traditional anesthetics but also positions companies favorably in a competitive landscape. By innovating in eco-friendly anesthetic formulations and practices, businesses can enhance their market presence and appeal to environmentally conscious healthcare providers, ultimately reshaping the future dynamics of the inhalation anesthesia industry.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Value Chain Analysis
• Case Study Analysis
• Regulatory Landscape
• Technology Analysis

Inhalation Anesthesia Market, By Drug

• Market Overview
• Sevoflurane
• Desflurane
• Isoflurane
• Others

Inhalation Anesthesia Market, By Application

• Market Overview
• Induction
• Maintenance

Inhalation Anesthesia Market, By End-Use

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Others

Healthcare Analytical Testing Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Baxter International Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Halocarbon Products Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Piramal Critical Care (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AbbVie Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fresenius Kabi AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Linde Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dragerwerk AG & Co. KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shenzhen Landwind Industry Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic Plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith's Group plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Penlon Ltd. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dameca A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soma Technology, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Narang Medical Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments